TCRT Alaunos Therapeutics, Inc.

$1.65 +1.54%

Updated 15 d ago

Healthcare · Pharmaceutical Preparations

Alaunos Therapeutics, Inc. (TCRT) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $4 million. Shares last traded at $1.65, 79.5% below their 52-week high. Over the past year the stock is down 44.6%. Revenue declined 50.0% year over year.

Market Cap

$4M

Shares Out

2.5M

EPS (TTM)

$-4.58

P/E Ratio

—

P/S Ratio

1393.03

P/B Ratio

6.41

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.02

52-Week Low

$1.56

Volume

Avg Vol (3m)

461.857

Performance

+4.78%

-18.56%

-31.46%

-38.04%

YTD

-49.38%

-44.61%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. TCRT split history →

Technicals

RSI (14)

38.69

SMA (50)

$1.96

SMA (200)

$2.73

Price vs SMA50

-16.20%

Price vs SMA200

-39.80%

ATR (14)

$0.09

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$0M

Net Income

$-4M

Gross Margin

—

Operating Margin

—

Net Margin

—

Return on Equity

-615.0%

Return on Assets

-264.5%

Current Ratio

0.77

Debt / Equity

0.00

Revenue Growth (YoY)

-50.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.85	2026-08-14
Q1 2026	$-0.59	2026-05-15
FY 2025	$-2.20	2026-03-31
Q3 2025	$-1.84	2025-11-14
Q2 2026	$-1.30	2026-08-14
Q1 2026	$-0.67	2026-05-15

Full earnings history →

Pharmaceutical Preparations peers

TCRT vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 15 d ago

P/S vs peers

1393.03 / 11.11 med

+12441% premium

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.